McLean Donna, McBride Olivia, Samardzic Tanja, Sisic Mia, Dellavalle Robert P, Tan Jerry
Windsor Clinical Research Inc, Windsor, Ontario, Canada.
University of Guelph, Guelph, Ontario, Canada.
JAAD Int. 2020 Oct 29;1(2):190-199. doi: 10.1016/j.jdin.2020.09.001. eCollection 2020 Dec.
Patient decision aids are tools that facilitate shared decision making when clinical evidence and patient values and preferences inform the process. Evidence-based guidelines have been developed for clinicians in hidradenitis suppurativa management. To address treatment decision-making needs of hidradenitis suppurativa patients, we developed a hidradenitis suppurativa patient decision aid.
To assess the efficacy of the hidradenitis suppurativa patient decision aid during treatment decision making.
An online, participant-blinded, parallel-group, randomized controlled trial of the hidradenitis suppurativa patient decision aid versus Mayo Clinic hidradenitis suppurativa website content (Mayo) was conducted with hidradenitis suppurativa patients. Outcomes were knowledge, decisional conflict, and preparation for decision making.
Forty participants fulfilled inclusion criteria and were randomized to hidradenitis suppurativa patient decision aid or Mayo. In the hidradenitis suppurativa patient decision aid group, data from 16 and 15 participants were analyzed at phases 1 and 2, respectively. In the Mayo group, data from 15 and 13 participants were analyzed at phases 1 and 2, respectively. Increased knowledge ( < .01) and preparation for decision making ( < .01), as well as reduced decisional conflict ( < .01), were observed in the hidradenitis suppurativa patient decision aid compared with the Mayo group.
The online methodology and recruitment from online hidradenitis suppurativa support groups limits generalizability of findings.
A hidradenitis suppurativa patient decision aid increased knowledge and preparation for decision making and reduced decisional conflict.
患者决策辅助工具是在临床证据以及患者价值观和偏好为决策过程提供信息时，促进共同决策的工具。针对临床医生在化脓性汗腺炎管理方面，已制定了循证指南。为满足化脓性汗腺炎患者的治疗决策需求，我们开发了一种化脓性汗腺炎患者决策辅助工具。
评估化脓性汗腺炎患者决策辅助工具在治疗决策过程中的效果。
对化脓性汗腺炎患者进行了一项在线、参与者盲法、平行组、随机对照试验，比较化脓性汗腺炎患者决策辅助工具与梅奥诊所化脓性汗腺炎网站内容（梅奥）。结果指标包括知识水平、决策冲突和决策准备情况。
40名参与者符合纳入标准，并被随机分为化脓性汗腺炎患者决策辅助工具组或梅奥组。在化脓性汗腺炎患者决策辅助工具组中，分别在第1阶段和第2阶段对16名和15名参与者的数据进行了分析。在梅奥组中，分别在第1阶段和第2阶段对15名和13名参与者的数据进行了分析。与梅奥组相比，化脓性汗腺炎患者决策辅助工具组的知识水平提高（<0.01）、决策准备情况改善（<0.01），且决策冲突减少（<0.01）。
在线研究方法以及从在线化脓性汗腺炎支持小组招募参与者限制了研究结果的普遍性。
化脓性汗腺炎患者决策辅助工具提高了知识水平和决策准备情况，并减少了决策冲突。
